Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumors.
Clin Cancer Res. 2011 May 15;17(10):3431-42. doi: 10.1158/1078-0432.CCR-10-2345. Epub 2011 Jan 10.
Clin Cancer Res. 2011.
PMID: 21220472
Clinical Trial.
Association between calciphylaxis and inflammation in two patients on chronic dialysis.
Slough S, Servilla KS, Harford AM, Konstantinov KN, Harris A, Tzamaloukas AH.
Slough S, et al.
Adv Perit Dial. 2006;22:171-4.
Adv Perit Dial. 2006.
PMID: 16983964
Item in Clipboard
In vivo characterisation of the small-conductance KCa (SK) channel activator 1-ethyl-2-benzimidazolinone (1-EBIO) as a potential anticonvulsant.
Anderson NJ, Slough S, Watson WP.
Anderson NJ, et al. Among authors: slough s.
Eur J Pharmacol. 2006 Sep 28;546(1-3):48-53. doi: 10.1016/j.ejphar.2006.07.007. Epub 2006 Jul 21.
Eur J Pharmacol. 2006.
PMID: 16925994
Item in Clipboard
First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2.
White HS, Watson WP, Hansen SL, Slough S, Perregaard J, Sarup A, Bolvig T, Petersen G, Larsson OM, Clausen RP, Frølund B, Falch E, Krogsgaard-Larsen P, Schousboe A.
White HS, et al. Among authors: slough s.
J Pharmacol Exp Ther. 2005 Feb;312(2):866-74. doi: 10.1124/jpet.104.068825. Epub 2004 Nov 18.
J Pharmacol Exp Ther. 2005.
PMID: 15550575
Item in Clipboard
Evidence that the novel imidazoline compound FT005 is an alpha(2)-adrenoceptor agonist.
Slough S, Guillaumet G, Taberner PV.
Slough S, et al.
Br J Pharmacol. 2002 Aug;136(7):1049-57. doi: 10.1038/sj.bjp.0704810.
Br J Pharmacol. 2002.
PMID: 12145105
Free PMC article.
Item in Clipboard
Cite
Cite